Relationship between plasma concentration and antihypertensive effect of the dihydropyridine calcium antagonist, benidipine, in rats

被引:11
作者
Kobayashi, H [1 ]
Kobayashi, S [1 ]
机构
[1] Kyowa Hakko Kogyo Co Ltd, Pharmaceut Res Labs, Analyt & Pharmacokinet Dept, Shizuoka 411, Japan
关键词
D O I
10.1111/j.2042-7158.1997.tb06070.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although benidipine hydrochloride, a hydrophobic and weakly cationic dihydropyridine calcium antagonist, has slow onset but long-lasting anti-hypertensive effect in experimental animals and man, after administration it rapidly disappears from the plasma. Correlation of the plasma concentration with reduction in blood pressure has been investigated in spontaneously hypertensive rats, and concentrations in the mesenteric artery were compared with those in plasma after oral and intravenous administration of benidipine to rats. After oral administration of benidipine to spontaneously hypertensive rats, the fall in blood pressure showed an anti-clock hysteresis phenomenon. Using concomitant analysis, plasma concentrations and anti-hypertensive activity could both be closely fitted to a one-compartment open model and the effect compartment for the pharmacological activity of benidipine could be described by a Hill equation. Concentrations in the mesenteric artery increased rapidly and then declined more slowly than in plasma. The mean residence time of benidipine in the mesenteric artery corresponded closely to the reciprocal of the rate constant for elimination of benidipine from the effect compartment. From these results it seems that benidipine is retained longer in the plasma membrane, an effective site, because of its physicochemical properties, and thus shows a more sustained anti-hypertensive effect than would be predicted from its disposition in plasma.
引用
收藏
页码:1200 / 1204
页数:5
相关论文
共 50 条
[21]   Relationship between plasma osteopontin concentration and improvement of augmentation index with antihypertensive the treatment [J].
Miyoshi, K. ;
Kurata, M. ;
Okura, T. ;
Nagao, T. ;
Jotoku, M. ;
Enomoto, D. ;
Irita, J. ;
Higaki, J. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 :S150-S151
[22]   EFFECT OF DIHYDROPYRIDINE CALCIUM ANTAGONIST ON PROTEINURIA IN PATIENTS WITH SIGNIFICANT PROTEINURIA [J].
Ho, Chee-Khun ;
Lau, Titus W. ;
Lee, Evan J. C. .
NEPHROLOGY, 2005, 10 :A266-A266
[23]   Aranidipine (MPC-1304), a new dihydropyridine calcium antagonist: A review of its antihypertensive action [J].
Ohashi, K ;
Ebihara, A .
CARDIOVASCULAR DRUG REVIEWS, 1996, 14 (01) :1-16
[24]   ANTIHYPERTENSIVE EFFECT OF FELODIPINE, A NEW CALCIUM-ANTAGONIST [J].
INOUE, T ;
OMOSU, M ;
HAYASHI, S ;
SAKAGUCHI, S ;
NAKAO, K ;
INUKAI, T ;
ODAGIRI, N ;
ONO, T .
FOLIA PHARMACOLOGICA JAPONICA, 1992, 100 (05) :453-462
[25]   ANTIHYPERTENSIVE EFFECT OF A NOVEL CALCIUM-ANTAGONIST, SD-3211, IN EXPERIMENTAL HYPERTENSIVE RATS [J].
TAKADA, T ;
MIYAWAKI, N ;
KAGEYAMA, M ;
MATSUNO, K ;
ISHIDA, N ;
YAMAUCHI, H ;
ISO, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 (06) :855-862
[26]   THE RECEPTOR OCCUPATION AND PLASMA-CONCENTRATION OF NKY-722, A WATER-SOLUBLE DIHYDROPYRIDINE-TYPE CALCIUM-ANTAGONIST, IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
UCHIDA, S ;
YAMADA, S ;
OHKURA, T ;
HESHIKIRI, M ;
YOSHIMI, A ;
SHIRAHASE, H ;
KIMURA, R .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (01) :217-223
[27]   Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine - Comment [J].
Yeleswaram, K .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) :159-159
[28]   Comment on “Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine” [J].
J. K. Madsen ;
J. D. Jensen ;
L. W. Jensen ;
E. B. Pedersen .
European Journal of Clinical Pharmacology, 1997, 52 :161-161
[29]   Comment on “Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine” [J].
K. Yeleswaram .
European Journal of Clinical Pharmacology, 1997, 52 (2) :159-159
[30]   AMLODIPINE, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST WITH A PARTICULARLY STRONG ANTIHYPERTENSIVE PROFILE [J].
FLECKENSTEIN, A ;
FREY, M ;
ZORN, J ;
FLECKENSTEINGRUN, G .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (17) :I21-I34